While its inactivation alone does not initiate lung adenocarcinoma, combined loss with p53 deletion and oncogenic KRAS activation (KPS model) drives more aggressive tumors than KRAS/p53 alone.121. Here, KRAS is linked to lung adenocarcinoma.